Annals of Clinical Microbiology and Antimicrobials · 2014 · 67 citations · 14 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsAntimicrobial Susceptibility TestingCarbapenem ResistanceAnal AbscessCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenemase EnzymesMinimum Inhibitory Concentration DeterminationMinimum Inhibitory Concentration TestingPolymyxin Resistance GenesPseudomonas Aeruginosa Resistance
BACKGROUND: Carbapenemase genes are one of the most frequent mechanisms reported in carbapenem-resistant P. aeruginosa; however, description of P. aeruginosa co-harbouring two or more carbapenemases is unusual. METHODS: In this study we evaluated the presence of carbapenemase genes and the clonality of P. aeruginosa isolates obtained from a hospital over a 12-year period. A total of 127 isolates of carbapenem-resistant P. aeruginosa recovered from 109 patients feces (four samples), rectal swab (three samples), nasal swab (one sample) and anal abscess (one sample), were evaluated. Minimum inhibitory concentrations of the following antibiotics imipenem, meropenem and polymyxin E were determined by broth microdilution. The molecular profile of isolates was evaluated by pulsed field gel electrophoresis (PFGE). PCR for the following carbapenemase genes blaIMP;blaSPM;blaVIM;blaSIM;blaNDM;blaKPC;blaGES and nucleotide sequencing to confirm the enzyme gene types were performed and compared with the database available on the Internet (BLAST-http://www.ncbi.nlm.nhi.gov/blast/). RESULTS: All isolates were carbapenem-resistant, their MIC50 and MIC90 were respectively 64 μg/mL and 256 μg/mL to imipenem and 32 μg/mL and 256 μg/mL to meropenem, all isolates except one (MIC = 8 mg/L) were susceptible to polymyxin E. The most frequent carbapenemase genes identified were blaSPM identified in 41 isolates (32%), followed by 10 with blakpc and 5 with blaVIM (3.9%). All belonged to the class SPM-1 and VIM-2. In 2011, one isolate harbouring three carbapenemase genes (SPM-1, VIM-2 and KPC-2) that belonged to a new clone was identified in a hematopoietic stem cell transplanted patient. Then, 19 carbapenem-resistant P. aeruginosa were identified in an outbreak that occurred in the bone marrow transplant unit, all positive for SPM-1 gene, and 9 (47.3%) harbored both SPM-1 and KPC. CONCLUSION: Our findings showed that PCR for KPC gene should be performed to evaluate carbapenem resistance in P. aeruginosa and that this agent can harbor more than one carbapenemase gene. Attention should be focused on the possible rapid spread of KPC in P. aeruginosa isolates and for the fact that P. aeruginosa may become a reservoir of this transmissible resistance mechanism.
14
Patricia A. Bradford, Simona Bratu, Carl Urban et al. · Clinical Infectious Diseases · 2004 · 487 citations · Full text
Rodrigo E. Mendes, Katia A. Kiyota, Jussimara Monteiro et al. · Journal of Clinical Microbiology · 2006 · 294 citations · Full text
María Virginia Villegas, Karen Lolans, Adriana Correa et al. · Antimicrobial Agents and Chemotherapy · 2007 · 292 citations · Full text
Emergence of NDM-1-producing Acinetobacter baumannii in China
Yan Chen, Zhihui Zhou, Yan Jiang et al. · Journal of Antimicrobial Chemotherapy · 2011 · 269 citations
Mariana Castanheira, Lalitagauri M. Deshpande, Anthony Costello et al. · Journal of Antimicrobial Chemotherapy · 2014 · 210 citations